Showing: 1 - 10 of 17 RESULTS
Analyst Estimate Briefing Numinus Wellness Inc Psychedelics

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer during the summer months. The fourth company initiated on this note is Numinus Wellness Inc. (TSXV: NUMI), with a C$1.10 12-month price target and buy rating while referring to the firm as “a diversified operator.” …

Briefing Numinus Wellness Inc Psychedelics

Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada to conduct its feasibility study on MDMA-assisted therapy to treat post-traumatic stress disorder. The health department recently issued a “letter of no objection”, allowing the proposed study to proceed. The single-arm, open-label safety and feasibility study is sponsored by the …

Analyst Estimate Briefing Bright Minds Biosciences Compass Pathways Cybin Inc Field Trip Health Mind Medicine Mindset Pharma Numinus Wellness Inc Psychedelics Small Pharma Inc

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing unmet need in mental health” and that this need has only been growing steadily but has been exacerbated by the COVID-19 pandemic. In this 27 page primer Sepehr Manochehry, their analyst, highlights COMPASS Pathways (NASDAQ: …

Briefing Numinus Wellness Inc Psilocybin Psychedelics

Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with KGK Science, whereby it will begin studying a psilocybin extract produced in its lab. The clinical trial is to study the safety and psychoactive properties of a Psilocybe mushroom product that has been extracted and …

Briefing Numinus Wellness Inc Psychedelics

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally released the much awaited news: the company has closed its $17.3 million financing. While not exactly the news hopeful shareholders were looking for, the closing of the financing appears to be the justification for the day-long halt. The financing saw …

Briefing Numinus Wellness Inc Psychedelics

Numinus Wellness To Acquire Mindspace Psychology Services Of Montreal

Numinus Wellness (TSXV: NUMI) is acquiring that of Mindspace Psychology Services, whom operates as Mindspace Wellbeing, a reported leader and pioneer in psychedelic programming. The quote-filled announcement was made this morning, with Numinus stating that it will enable the company to provide an evidence-based psychedelic assisted psychotherapy program to patients. The release this morning began …